Hinge Health Inc. (NYSE:HNGE) Stock Has Consensus Price Target of $105.33

Posted by on Oct 9th, 2026

Shares of Hinge Health Inc. (NYSE:HNGE – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the nineteen brokerages that are covering the company, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation, fifteen have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $105.33.

Several brokerages have weighed in on HNGE. Citizens Jmp lifted their target price on Hinge Health from $96.00 to $107.00 and gave the company a “market outperform” rating in a research note on Wednesday, August 5th. Morgan Stanley increased their price objective on shares of Hinge Health from $72.00 to $108.00 and gave the company an “overweight” rating in a report on Monday, July 13th. Weiss Ratings upgraded shares of Hinge Health from a “sell (d-)” rating to a “hold (c)” rating in a research note on Tuesday, September 22nd. Bank of America started coverage on Hinge Health in a research report on Tuesday, September 29th. They issued a “buy” rating and a $110.00 target price for the company. Finally, Robert W. Baird increased their price target on Hinge Health from $85.00 to $90.00 and gave the company a “neutral” rating in a research note on Tuesday, September 22nd.

Get Our Latest Stock Analysis on Hinge Health

Insider Buying and Selling

In related news, CEO Daniel Perez sold 4,100 shares of the stock in a transaction that occurred on Tuesday, October 6th. The shares were sold at an average price of $100.20, for a total transaction of $410,820.00. Following the completion of the sale, the chief executive officer directly owned 4,100 shares of the company’s stock, valued at $410,820. This represents a 50.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President James Pursley sold 33,000 shares of the firm’s stock in a transaction that occurred on Monday, September 21st. The stock was sold at an average price of $94.14, for a total transaction of $3,106,620.00. Following the sale, the president owned 666,909 shares of the company’s stock, valued at $62,782,813.26. The trade was a 4.71% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 776,861 shares of company stock worth $70,085,397 in the last ninety days. Insiders own 18.92% of the company’s stock.

Institutional Investors Weigh In On Hinge Health

Large investors have recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd acquired a new position in Hinge Health in the 4th quarter worth approximately $26,000. IFP Advisors Inc raised its stake in Hinge Health by 140.0% during the 2nd quarter. IFP Advisors Inc now owns 324 shares of the company’s stock valued at $27,000 after purchasing an additional 189 shares during the period. Nykredit A S purchased a new stake in shares of Hinge Health in the second quarter valued at $29,000. CENTRAL TRUST Co purchased a new stake in shares of Hinge Health in the first quarter valued at $37,000. Finally, State of Wyoming acquired a new stake in shares of Hinge Health in the first quarter worth $110,000.

Hinge Health Trading Up 0.1%

Shares of Hinge Health stock opened at $98.00 on Friday. The stock has a market capitalization of $7.91 billion, a price-to-earnings ratio of 76.56 and a beta of 1.37. Hinge Health has a twelve month low of $30.08 and a twelve month high of $100.36. The business’s 50 day simple moving average is $90.69 and its 200-day simple moving average is $70.98.

Hinge Health (NYSE:HNGE – Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.28 by $0.31. The company had revenue of $212.82 million during the quarter. Hinge Health had a net margin of 15.15% and a return on equity of 51.60%. The business’s revenue was up 53.0% compared to the same quarter last year. During the same period last year, the firm posted $0.59 EPS. Sell-side analysts predict that Hinge Health will post 1.25 earnings per share for the current year.

Hinge Health Company Profile

(Get Free Report)

Hinge Health, Inc is a digital healthcare company focused on musculoskeletal (MSK) conditions, including back and joint pain. The company provides virtual care designed to help members manage pain, improve mobility and avoid or delay more invasive treatments.

Its platform combines a mobile application, motion-sensing technology, personalized exercise therapy, education and support from a care team that may include clinical specialists. Hinge Health offers programs for conditions such as chronic back pain, knee pain and other common MSK issues, with services generally provided through employers, health plans and other healthcare organizations.

Hinge Health was founded in 2015 and is headquartered in San Francisco, California.

Featured Articles

Analyst Recommendations for Hinge Health (NYSE:HNGE)

Receive News & Ratings for Hinge Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hinge Health and related companies with MarketBeat.com's FREE daily email newsletter.